Hematopoietic Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Arch Iran Med. 2022 Dec 1;25(12):798-806. doi: 10.34172/aim.2022.125.
Human leukocyte antigen (HLA) molecules mediate critical roles in determining responsiveness or non-responsiveness of the immune system, especially in transplantation. Some studies have shown a possible association between certain HLA alleles and some allogeneic hematopoietic stem cell transplantation (allo-HSCT) outcomes such as acute/chronic graft-versus-host disease (aGVHD/cGVHD) and overall survival (OS). In the current study, we investigated any possible association of HLA subclasses and acute/chronic GVHD occurrence as well as OS in patients receiving HLA-matched sibling allo-HSCT.
We retrospectively evaluated the association of various HLA alleles with the incidence of aGVHD, cGVHD, and OS of 162 patients who received allo-HSCT from HLA-matched sibling between 2009-2018 at Taleghani hospital in Tehran.
We found that the incidence of aGVHD grades II-IV was higher among patients who had HLA-B07 (=0.031) and HLA-DRB107 (=0.052). The presence of HLA-A01 was associated with 4.5-fold greater odds of incidence in the extensive-type of cGVHD (=0.009). Furthermore, HLA-A03 (=0.089), HLA-B13(=0.013), HLA-B40 (=0.042), HLA-DRB102 (=0.074), and HLA-DRB104 (=0.039) were associated with a lower rate of OS.
This study suggests that certain HLA alleles might influence the incidence and severity of acute or chronic GVHD in the context of HLA-matched sibling allo-HSCT. In addition, some specific HLA alleles help predict OS in allo-HSCT recipients. These results might be helpful in estimating the incidence of aGVHD, cGVHD, and OS as well as designing personalized therapy.
人类白细胞抗原 (HLA) 分子在决定免疫系统的反应性或非反应性方面发挥着关键作用,尤其是在移植中。一些研究表明,某些 HLA 等位基因与某些异基因造血干细胞移植 (allo-HSCT) 结果之间可能存在关联,例如急性/慢性移植物抗宿主病 (aGVHD/cGVHD) 和总生存 (OS)。在本研究中,我们研究了 HLA 亚类与接受 HLA 匹配的同胞 allo-HSCT 的患者发生急性/慢性 GVHD 以及 OS 的可能性关联。
我们回顾性评估了 2009 年至 2018 年间在德黑兰 Taleghani 医院接受 HLA 匹配同胞 allo-HSCT 的 162 名患者的各种 HLA 等位基因与 aGVHD、cGVHD 和 OS 发生率的关联。
我们发现 HLA-B07(=0.031)和 HLA-DRB107(=0.052)的患者发生 aGVHD Ⅱ-Ⅳ级的发生率较高。HLA-A01 的存在与广泛型 cGVHD 的发生率增加 4.5 倍有关(=0.009)。此外,HLA-A03(=0.089)、HLA-B13(=0.013)、HLA-B40(=0.042)、HLA-DRB102(=0.074)和 HLA-DRB104(=0.039)与 OS 率降低有关。
本研究表明,某些 HLA 等位基因可能影响 HLA 匹配同胞 allo-HSCT 中急性或慢性 GVHD 的发生率和严重程度。此外,某些特定的 HLA 等位基因有助于预测 allo-HSCT 受者的 OS。这些结果可能有助于估计 aGVHD、cGVHD 和 OS 的发生率,并设计个性化治疗。